Astrid Isberg

Associate
  • Malmö
  • Languages:
    Swedish, English, French

Education

  • Lund University, master of laws LL.M.,

Experience

  • Advokatfirman Vinge, 2016 - 
  • Legal Secondee, Trelleborg AB (publ), February – August 2020
  • Summer trainee Mannheimer Swartling Lawfirm, 2015
  • Intern at Ministry of Foreign Affairs, 2015
  • Summer trainee Vinge Malmö, 2014

 

 

Mandate

Mandate December 18, 2020

Vinge advises Fastighets AB Trianon in connection with its listing on Nasdaq Stockholm

Vinge has advised Fastighets AB Trianon (publ) in connection with its list change from Nasdaq First…

Mandate December 10, 2020

Vinge advised Active Biotech on its rights offering

Vinge advised Active Biotech AB (publ) in connection with its rights offering.

Mandate November 22, 2019

Vinge assists Lantmännen in connection with issue of subordinated debentures

Lantmännen co operative association has published a prospectus in relation to an offer to subscribe…

Mandate September 23, 2019

Vinge advises Vicore Pharma in connection with its listing on Nasdaq Stockholm

Vinge advises Vicore Pharma Holding AB (publ) in connection with its list change from Nasdaq First N…

Mandate July 02, 2019

Vinge has acted for Bergs Timber in connection with its acquisition of Fågelfors Hyvleri and refinancing

Vinge has acted for Bergs Timber in connection with its acquisition of all shares in AB Fågelfors Hy…

Mandate May 23, 2019

Vinge advises Veoneer in connection with its USD 600 million capital raise

Veoneer, Inc. (“Veoneer”) has completed a USD 600 million capital raise, consisting of two concurren…

Mandate September 25, 2018

Vinge advised Cantargia on its Nasdaq Stockholm main market listing

The shares of Cantargia AB (publ) have been admitted to trading on the main market of Nasdaq Stockho…

Mandate September 10, 2018

Vinge advised IBT on its Nasdaq Stockholm main market listing

The shares of Infant Bacterial Therapeutics AB (publ) have been admitted to trading on the main mark…

Mandate July 11, 2018

Vinge advised BIMobject on directed share issue

BIMobject AB (publ) has completed a directed share issue of SEK 240 million to EQT Ventures.

Mandate April 11, 2018

Vinge advises Wilson Therapeutics in connection with the offer from Alexion

Alexion has announced a public cash offer to the shareholders of Wilson Therapeutics AB.

Mandate March 04, 2018

Vinge advises Enea

Enea AB (publ) has signed an agreement to acquire Openwave Mobility for USD 90 million and has issue…

Mandate February 15, 2018

Vinge advises Active Biotech on rights offering

Active Biotech AB (publ) issues new shares with pre-emptive rights for the shareholders.

Mandate December 12, 2017

Vinge advises Wilson Therapeutics in connection with directed share issue

Vinge has advised Wilson Therapeutics on a directed new issue of shares, whereby Wilson Therapeutics…

Mandate November 27, 2017

Vinge advises Sigrid Therapeuctis AB on share issues

Vinge has advised Sigrid Therapeuctis AB in connection with a combined directed issue and rights off…

Mandate November 24, 2017

Vinge advises IBT on share issues

Vinge advises Infant Bacterial Therapeutics AB (publ) (Nasdaq First North Premier) in connection wit…

Mandate November 02, 2017

Vinge advised Orexo on bond issue

Orexo AB (publ) has issued a four-year senior unsecured bond loan of SEK 325 million, within a frame…

Mandate October 26, 2017

Vinge advised Enea on directed share issue

Vinge has advised Enea AB (publ) in connection with a directed share issue of SEK 141 million throug…

Mandate June 26, 2017

Vinge advises Trianon

Vinge advises Fastighets AB Trianon (publ) in connection with the acquisition of the Entré propertie…

Mandate May 23, 2017

Vinge advises Medicover in relation to its listing on Nasdaq Staockholm

Vinge advises Medicover AB (publ) (“Medicover”) and its main shareholder Celox Holding AB (“Celox”),…